Bacterial peptidoglycan-degrading enzymes and their impact on host muropeptide detection

Journal of Innate Immunity

Volumn 1, Issue 2, 2009, Pages 88-97

  Humann, Jessica ^a   Lenz, Laurel L ^a,b  

^a UNIVERSITY OF COLORADO   (United States)

^b DEPARTMENT OF MEDICINE   (United States)

Author keywords

Autolysin; Bacteria; Peptidoglycan; Subversion

Indexed keywords

AUTOLYSIN; BACTERIAL ENZYME; GLYCOLYTIC ENZYME; GLYCOPEPTIDE; GLYCOSYLTRANSFERASE; HYDROLASE; LYSOZYME; MURAMYL DIPEPTIDE; MUROPEPTIDE; N ACETYLGLUCOSAMINE; N ACETYLMURAMOYLALANINE AMIDASE; PEPTIDE; PEPTIDOGLYCAN; UNCLASSIFIED DRUG;

BACILLUS SUBTILIS; BACTERIAL MEMBRANE; BACTERIAL VIRULENCE; BACTERIUM DETECTION; BORDETELLA PERTUSSIS; ENZYME STRUCTURE; EUKARYOTE; HELICOBACTER PYLORI; HOST RESISTANCE; IMMUNE RESPONSE; IMMUNOMODULATION; INNATE IMMUNITY; LISTERIA MONOCYTOGENES; MYCOBACTERIUM TUBERCULOSIS; NEISSERIA GONORRHOEAE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN HYDROLYSIS; PROTEIN MODIFICATION; PROTEIN SECRETION; PROTEIN STRUCTURE; REVIEW; SPORE GERMINATION; STREPTOCOCCUS PNEUMONIAE;

AMINO ACID SEQUENCE; ANIMALS; BACTERIA; BACTERIAL INFECTIONS; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNITY, INNATE; MICE; N-ACETYLMURAMOYL-L-ALANINE AMIDASE; PEPTIDOGLYCAN; PROTEIN STRUCTURE, TERTIARY;

EID: 60849098840     PISSN: 1662811X     EISSN: 16628128     Source Type: Journal    
DOI: 10.1159/000181181     Document Type: Review

References (78)

1. Bourhis LL, Werts C: Role of Nods in bacterial infection. Microbes Infect 2007; 9:629- 636.
2. Guan R, Roychowdhury A, Ember B, Kumar S, Boons GJ, Mariuzza RA: Structural basis for peptidoglycan binding by peptidoglycan recognition proteins. Proc Natl Acad Sci USA 2004; 101:17168-17173.
3. Vollmer W, Blanot D, de Pedro MA: Peptido-glycan structure and architecture. FEMS Microbiol Rev 2008; 32:149-167.
4. Brennan PJ: Structure, function, and biogenesis of the cell wall of Mycobacterium tuberculosis . Tuberculosis (Edinb) 2003; 83: 91 - 97.
5. Traub S, von Aulock S, Hartung T, Hermann C: MDP and other muropeptides - direct and synergistic effects on the immune system. J Endotoxin Res 2006; 12:69-85.
6. Vollmer W, Tomasz A: Peptidoglycan N-acetylglucosamine deacetylase, a putative virulence factor in Streptococcus pneumo-niae . Infect Immun 2002; 70: 7176 -7178.
7. Boneca IG, Dussurget O, Cabanes D, Nahori M A, Sousa S, Lecuit M, Psylinakis E , Bourio -tis V, Hugot JP, Giovannini M, Coyle A, Bertin J, Namane A, Rousselle JC, Cayet N, Prevost MC, Balloy V, Chignard M, Philpott DJ, Cossart P, Girardin SE: A critical role for peptidoglycan N-deacetylation in Listeria evasion from the host innate immune system. Proc Natl Acad Sci USA 2007; 104:997-1002.
8. Bera A, Biswas R, Herbert S, Kulauzovic E, Weidenmaier C, Peschel A, Gotz F: Influence of wall teichoic acid on lysozyme resistance in Staphylococcus aureus . J Bacteriol 2007; 189:280-283.
9. Ehlert K, Schroder W, Labischinski H: Specificities of FemA and FemB for different gly-cine residues: FemB cannot substitute for FemA in staphylococcal peptidoglycan pen-taglycine side chain formation. J Bacteriol 1997; 179:7573-7576.
10. Hegde SS, Shrader TE: FemABX family members are novel nonribosomal peptidyl-transferases and important pathogen-specific drug targets. J Biol Chem 2001; 276: 6998-7003.
11. Sugai M, Fujiwara T, Ohta K, Komatsuzawa H, Ohara M, Suginaka H: epr , which encodes glycylglycine endopeptidase resistance, is homologous to femAB and affects serine content of peptidoglycan cross bridges in Staphylococcus capitis and Staphylococcus aureus . J Bacteriol 1997; 179:4311-4318.
12. Atrih A, Bacher G, Allmaier G, Williamson MP, Foster SJ: Analysis of peptidoglycan structure from vegetative cells of Bacillus subtilis 168 and role of PBP 5 in peptidogly-can maturation. J Bacteriol 1999; 181:3956- 3966.
13. Keep NH, Ward JM, Cohen-Gonsaud M, Henderson B: Wake up! Peptidoglycan lysis and bacterial non-growth states. Trends Mi-crobiol 2006; 14:271-276.
14. Kana BD, Gordhan BG, Downing KJ, Sung N, Vostroktunova G, Machowski EE, Tseno-va L, Young M, Kaprelyants A, Kaplan G, Mizrahi V: The resuscitation-promoting factors of Mycobacterium tuberculosis are required for virulence and resuscitation from dormancy but are collectively dispensable for growth in vitro. Mol Microbiol 2008; 67: 672- 684.
15. Russell-Goldman E, Xu J, Wang X, Chan J, Tufariello JM: A Mycobacterium tuberculosis Rpf double-knockout strain exhibits profound defects in reactivation from chronic tuberculosis and innate immunity pheno-ty pes. Infect Immun 20 08; 76: 4269-4281.
16. Fournier B, Philpott DJ: Recognition of Staphylococcus aureus by the innate immune system. Clin Microbiol Rev 2005; 18:521- 540.
17. Scheurwater EM, Pfeffer JM, Clarke AJ: Production and purification of the bacterial au-tolysin N-acetylmuramoyl-L-alanine ami-dase B from Pseudomonas aeruginosa. Protein Expr Purif 2007; 56:128-137.
18. Scheurwater E, Reid CW, Clarke AJ: Lytic transglycosylases: bacterial space-making autolysins. Int J Biochem Cel l Biol 20 08; 40: 586-591.
19. Zahrl D, Wagner M, Bischof K, Bayer M, Za-vecz B, Beranek A, Ruckenstuhl C, Zarfel GE, Koraimann G: Peptidoglycan degradation by specialized lytic transglycosylases associated with type III and type IV secretion systems. Microbiology 2005; 151:3455-3467.
20. Cloud-Hansen KA, Hackett KT, Garcia DL, Dillard JP: Neisseria gonorrhoeae uses two lytic transglycosylases to produce cytotoxic peptidoglycan monomers. J Bacteriol 2008; 190:5989-5994.
21. Park JT, Uehara T: How bacteria consume their own exoskeletons (turnover and recycling of cell wall peptidoglycan). Microbiol Mol Biol Rev 2008; 72: 211-227.
22. Cookson BT, Cho HL, Herwaldt LA, Goldman WE: Biological activities and chemical composition of purified tracheal cytotoxin of Bordetella pertussis . Infect Immun 1989; 57: 2223-2229.
23. Cookson BT, Tyler AN, Goldman WE: Primary structure of the peptidoglycan-derived tracheal cytotoxin of Bordetella pertussis. Biochemistry 1989; 28: 1744 -1749.
24. Martin SA, Karnovsky ML, Krueger JM, Pappenheimer JR, Biemann K: Peptidogly-cans as promoters of slow-wave sleep. I. Structure of the sleep-promoting factor isolated from human urine. J Biol Chem 1984; 259:12652-12658.
25. Melly MA, McGee ZA, Rosenthal RS: Ability of monomeric peptidoglycan fragments from Neisseria gonorrhoeae to damage human fallopian-tube mucosa. J Infect Dis 1984; 149:378-386.
26. Sinha RK, Rosenthal RS: Release of soluble peptidoglycan from growing conococci: demonstration of anhydro-muramyl-containing fragments. Infect Immun 1980; 29:914-925.
27. Anantharaman V, Aravind L: Evolutionary history, structural features and biochemical diversity of the NlpC/P60 superfamily of enzymes. Genome Biol 2003; 4:R11.
28. Fukushima T, Afkham A, Kurosawa S, Ta-nabe T, Yamamoto H, Sekiguchi J: A new D , L -endopeptidase gene product , YojL (renamed CwlS), plays a role in cell separation with LytE and LytF in Bacillus subtilis. J Bac-teriol 2006; 188:5541-5550.
29. Schubert K , Bichlmaier A , Mager E , Wolff K, Ruhland G, Fiedler F: P45, an extracellular 45 kDa protein of Listeria monocytogenes with similarity to protein p60 and exhibiting peptidoglycan lytic activity. Arch Microbiol 2000; 173:21-28.
30. Lenz LL, Mohammadi S, Geissler A, Portnoy DA: SecA2-dependent secretion of autolytic enzymes promotes Listeria monocytogenes pathogenesis. Proc Natl Acad Sci USA 2003; 100:12432-12437.
31. Bateman A, Rawlings ND: The CHAP domain: a large family of amidases including GSP amidase and peptidoglycan hydrolases. Trends Biochem Sci 2003; 28:234-237.
32. Layec S, Decaris B, Leblond-Bourget N: Characterization of proteins belonging to the CHAP-related superfamily within the Firmicutes. J Mol Microbiol Biotechnol 2008; 14:31-40.
33. Donovan DM, Foster-Frey J, Dong S, Rousseau GM, Moineau S, Pritchard DG: The cell lysis activity of the Streptococcus agalactiae bacteriophage B30 endolysin relies on the cysteine, histidine-dependent amidohydro-lase/peptidase domain. Appl Environ Mi-crobiol 2006; 72: 510 8 -5112 .
34. Rashel M, Uchiyama J, Takemura I, Hoshiba H, Ujihara T, Takatsuji H, Honke K, Matsu-zaki S: Tail-associated structural protein gp61 of Staphylococcus aureus phage phi MR11 has bifunctional lytic activity. FEMS Microbiol Lett 2008; 284:9-16.
35. Vollmer W, Joris B, Charlier P, Foster S: Bacterial peptidoglycan (murein) hydrolases. FEMS Microbiol Rev 2008; 32:259-286.
36. Limpens E, Franken C, Smit P, Willemse J, Bisseling T, Geurts R: LysM domain receptor kinases regulating rhizobial Nod factor-induced infection. Science 2003; 302: 630 -633.
37. Madsen EB, Madsen LH, Radutoiu S, Olbryt M, Rakwalska M, Szczyglowski K, Sato S, Kaneko T, Tabata S, Sandal N, Stougaard J: A receptor kinase gene of the LysM type is involved in legume perception of rhizobial sig-na ls. Nature 2003; 425: 637- 640.
38. Travassos LH, Girardin SE, Philpott DJ, Bla-not D, Nahori MA, Werts C, Boneca IG: Tolllike receptor 2-dependent bacterial sensing does not occur via peptidoglycan recognition. EMBO Rep 2004; 5:1000-1006.
39. Dziarski R, Gupta D: Staphylococcus aureus peptidoglycan is a toll-like receptor 2 activator: a reeva luation. Infect Immun 2005; 73: 5212-5216.
40. Dziarski R: Peptidoglycan recognition proteins (PGR Ps). Mol Immunol 20 04; 40: 877- 886.
41. Gupta D: Peptidoglycan recognition proteins-maintaining immune homeostasis and normal development. Cell Host Microbe 2008; 3: 273-274.
42. Lhocine N, Ribeiro PS, Buchon N, Wepf A, Wilson R, Tenev T, Lemaitre B, Gstaiger M, Meier P, Leulier F: PIMS modulates immune tolerance by negatively regulating Drosophi-la innate immune signaling. Cell Host Microbe 2008;4:147 - 158.
43. Maillet F, Bischoff V, Vignal C, Hoffmann J, Royet J: The Drosophila peptidoglycan recognition protein PGRP-LF blocks PGRP-LC and IMD/JNK pathway activation. Cell Host Microbe 2008; 3:293-303.
44. McDonald C, Inohara N, Nunez G: Peptido-glycan signaling in innate immunity and inflammatory disease. J Biol Chem 2005; 280: 20177-20180.
45. Cho S, Wang Q, Swaminathan CP, Hesek D, Lee M, Boons GJ, Mobashery S, Mariuzza RA: Structural insights into the bactericidal mechanism of human peptidoglycan recognition proteins. Proc Natl Acad Sci USA 2007; 104:8761-8766.
46. Wang ZM, Li X, Cocklin RR, Wang M, Fu-kase K, Inamura S, Kusumoto S, Gupta D, Dziarski R: Human peptidoglycan recognition protein-L is an N-acetylmuramoyl-L-alanine amidase. J Biol Chem 2003; 278: 49044-49052.
47. Hoijer MA, Melief MJ, Debets R, Hazenberg MP: Inflammatory properties of peptidogly-can are decreased after degradation by human N-acetylmuramyl-L- alanine amidase. Eur Cytokine Netw 1997; 8:375-381.
48. Choe KM, Werner T, Stoven S, Hultmark D, Anderson KV: Requirement for a peptido-glycan recognition protein (PGRP) in Relish activation and antibacterial immune responses in Drosophila . Science 2002; 296: 359-362.
49. Gottar M, Gobert V, Michel T, Belvin M, Duyk G, Hoffmann JA, Ferrandon D, Royet J: The Drosophila immune response against Gram-negative bacteria is mediated by a peptidoglycan recognition protein. Nature 2002; 416:640-644.
50. Ramet M, Manfruelli P, Pearson A, Mathey-Prevot B, Ezekowitz RA: Functional genom-ic analysis of phagocytosis and identification of a Drosophila receptor for E. coli. Nature 2002;416:644-648.
51. Xu M, Wang Z, Locksley RM: Innate immune responses in peptidoglycan recognition protein L-deficient mice. Mol Cell Biol 2004;24:7949-7957.
52. Chamaillard M, Girardin SE, Viala J, Phil-pott DJ: Nods, Nalps and Naip: intracellular regulators of bacterial-induced inflammation. Cell Microbiol 2003;5:581-592.
53. Sirard JC, Vignal C, Dessein R, Chamaillard M: Nod-like receptors: cytosolic watchdogs for immunity against pathogens. PLoS Pat-hog 2007; 3:e152.
54. Hampe J, Cuthbert A, Croucher PJ, Mirza MM, Mascheretti S, Fisher S, Frenzel H, King K, Hasselmeyer A, MacPherson AJ, Bridger S, van Deventer S, Forbes A, Niko-laus S, Lennard-Jones JE, Foelsch UR, Kraw-czak M, Lewis C, Schreiber S, Mathew CG: Association between insertion mutation in NOD2 gene and Crohn's disease in German a nd British popu lat ions. Lancet 2001; 357: 1925-1928.
55. Hugot JP, Chamaillard M, Zouali H, Lesage S, Cezard JP, Belaiche J, Almer S, Tysk C, O'Morain CA, Gassull M, Binder V, Finkel Y, Cortot A, Modigliani R, Laurent-Puig P, Gower-Rousseau C, Macry J, Colombel JF, Sahbatou M, Thomas G: Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 2001; 411:599-603.
56. Ogura Y, Bonen DK, Inohara N, Nicolae DL, Chen FF, Ramos R, Britton H, Moran T, Karaliuskas R, Duerr RH, Achkar JP, Brant SR, Bayless TM, Kirschner BS, Hanauer SB, Nunez G, Cho JH: A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 2001; 411:603-606.
57. Girardin SE, Boneca IG, Viala J, Chamaillard M, Labigne A, Thomas G, Philpott DJ, San-sonetti PJ: Nod2 is a general sensor of pepti-doglycan through muramyl dipeptide (MDP) detection. J Biol Chem 2003; 278:8869-8872.
58. Inohara N, Ogura Y, Fontalba A, Gutierrez O, Pons F, Crespo J, Fukase K, Inamura S, Kusu-moto S, Hashimoto M, Foster SJ, Moran AP, Fernandez-Luna JL, Nunez G: Host recognition of bacterial muramyl dipeptide mediated through NOD2. Implications for Crohn's disease. J Biol Chem 2003; 278:5509-5512.
59. Girardin SE, Boneca IG, Carneiro LA, Anti-gnac A, Jehanno M, Viala J, Tedin K, Taha MK, Labigne A, Zahringer U, Coyle AJ, Di-Stefano PS, Bertin J, Sansonetti PJ, Philpott DJ: Nod1 detects a unique muropeptide from Gram-negative bacterial peptidoglycan. Science 2003; 300: 1584-1587.
60. Martinon F, Agostini L, Meylan E, Tschopp J: Identification of bacterial muramyl dipep-tide as activator of the NALP3/cryopyrin in-flammasome. Curr Biol 2004; 14: 1929-1934.
61. Pan Q, Mathison J, Fearns C, Kravchenko VV, Da Silva Correia J, Hoffman HM, Ko-bayashi KS, Bertin J, Grant EP, Coyle AJ, Sut-terwala FS, Ogura Y, Flavell RA, Ulevitch RJ: MDP-induced interleukin-1ß processing requires Nod2 and CIAS1/NALP3. J Leukoc Biol 2007;82:177-183.
62. Hoffman HM, Mueller JL, Broide DH, Wanderer AA, Kolodner RD: Mutation of a new gene encoding a putative pyrin-like protein causes familial cold autoinflammatory syndrome and Muckle-Wells syndrome. Nat Genet 2001; 29:301-305.
63. Hysi P, Kabesch M, Moffatt MF, Schedel M, Carr D, Zhang Y, Boardman B, von Mutius E, Weiland SK, Leupold W, Fritzsch C, Klopp N, Musk AW, James A, Nunez G, Inohara N, Cookson WO: NOD1 variation, immunoglobulin E and asthma. Hum Mol Genet 2005;14:935-941.
64. Garcia DL, Dillard JP: AmiC functions as an N-acetylmuramyl-L-alanine amidase necessary for cell separation and can promote autolysis in Neisseria gonorrhoeae. J Bacteriol 2006; 188: 7211-7221.
65. Cloud KA, Dillard JP: A lytic transglycosyl-ase of Neisseria gonorrhoeae is involved in peptidoglycan-derived cytotoxin production. Infect Immun 2002;70:2752-2757.
66. Garcia DL, Dillard JP: Mutations in ampG or ampD affect peptidoglycan fragment release from Neisseria gonorrhoeae . J Bacteriol 2008; 190:3799-3807.
67. Swaminathan CP, Brown PH, Roychowd-hury A, Wang Q, Guan R, Silverman N, Goldman WE, Boons GJ, Mariuzza RA: Dual strategies for peptidoglycan discrimination by peptidoglycan recognition proteins (PGRPs). Proc Natl Acad Sci USA 2006; 103: 684-689.
68. Rambow-Larsen AA, Weiss AA: The PtlE protein of Bordetella pertussis has peptido-glycanase activity required for Ptl-mediated pertussis toxin secretion. J Bacteriol 2002; 184:2863-2869.
69. Viala J, Chaput C, Boneca IG, Cardona A, Girardin SE, Moran AP, Athman R, Memet S, Huerre MR, Coyle AJ, DiStefano PS, Sansonetti PJ, Labigne A, Bertin J, Philpott DJ, Fer-rero RL: Nod1 responds to peptidoglycan delivered by the Helicobacter pylori cag pathogenicity island. Nat Immunol 2004; 5: 1166-1174.
70. Boneca IG: The role of peptidoglycan in pathogenesis. Curr Opin Microbiol 2005; 8: 46-53.
71. Costa K, Bacher G, Allmaier G, Dominguez-Bello MG, Engstrand L, Falk P, de Pedro MA, Garcia-del Portillo F: The morphological transition of Helicobacter pylori cells from spiral to coccoid is preceded by a substantial modification of the cell wall. J Bacteriol 1999;181:3710-3715.
72. Chaput C, Ecobichon C, Cayet N, Girardin SE, Werts C, Guadagnini S, Prevost MC, Mengin-Lecreulx D, Labigne A, Boneca IG: Role of AmiA in the morphological transition of Helicobacter pylori and in immune escape. PLoS Pathog 2006; 2:e97.
73. Rosenstiel P, Hellmig S, Hampe J, Ott S, Till A, Fischbach W, Sahly H, Lucius R, Folsch UR, Philpott D, Schreiber S: Influence of polymorphisms in the NOD1/CARD4 and NOD2/CARD15 genes on the clinical outcome of Helicobacter pylori infection. Cell Microbiol 2006; 8:1188-1198.
74. Humann J, Bjordahl R, Andreasen K, Lenz LL: Expression of the p60 autolysin enhances NK cell activation and is required for Listeria monocytogenes expansion in IFN-γ-responsive mice. J Immunol 2007; 178:2407-2414.
75. Schultheis RJ, Kearns RJ: In vivo administration of anti-asialo-GM1 antibody enhances splenic clearance of Listeria monocytogenes. Nat Immun Cell Growth Regul 1990; 9:376-386.
76. Teixeira HC, Kaufmann SH: Role of NK1.1+ cells in experimental listeriosis: NK1+ cells are early IFN-γ producers but impair resistance to Listeria monocytogenes infection. J Immunol 1994;152:1873-1882.
77. Wang L, Lin M: Identification of IspC, an 86-kilodalton protein target of humoral immune response to infection with Listeria monocytogenes serotype 4b, as a novel surface autolysin. J Bacteriol 2007; 189:2046-2054.
78. Wang L, Lin M: A novel cell wall-anchored peptidoglycan hydrolase (autolysin), IspC, essential for Listeria monocytogenes virulence: genetic and proteomic analysis. Microbiology 2008; 154: 1900-1913.